Signal · Product Feed

Ibandronate Sodium Catalog No.:M8787-2 PubMed PMID: 19122279

Ibandronate Sodium Catalog No.:M8787-2 PubMed PMID: 19122279

Name: Ibandronate Sodium Catalog No.:M8787-2 PubMed PMID: 19122279
Brand: juliusking.com
SKU: 39512010510
Price: 119.00 USD
Availability: InStock
Rating: 4.560700000000001 (14 reviews)

SKU: 39512010510

4.6

USD119.00 USD140.00

Pay in 4 interest-free payments of $29.75 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 9 - Aug 14

Live Spec

Ibandronate Sodium Catalog No.:M8787-2 PubMed PMID: 19122279Ibandronate sodium is a potent bisphosphonate drug developed by Hoffman La Roche and used in the prevention and treatment of osteoporosis and metastasis associated skeletal fractures in people with cancer. It may also be used to treat hypercalcemia (elevated blood calcium levels). Ibandronate is indicated for the treatment and prevention of osteoporosis in post menopausal women. In May 2003, the U. S. Food and Drug Administration (FDA) approved

Store: juliusking.com · Domain: juliusking.com

Description

PubMed PMID: 19122279

7(8):1447-52

2018 Aug 9

CAS Number: 135575-42-7

and is 18- and 2-fold less potent than (-)-nicotine at human α4β2 and a7 nAChR

Exchange/Return Notes